{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:52:49Z","timestamp":1761807169287},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2005,5,31]],"date-time":"2005-05-31T00:00:00Z","timestamp":1117497600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1007\/s10067-005-1104-y","type":"journal-article","created":{"date-parts":[[2005,5,30]],"date-time":"2005-05-30T13:53:53Z","timestamp":1117461233000},"page":"673-676","source":"Crossref","is-referenced-by-count":34,"title":["Anti-CCP and antikeratin antibodies in rheumatoid arthritis, primary Sj\u00f6gren\u2019s syndrome, and Wegener\u2019s granulomatosis"],"prefix":"10.1007","volume":"24","author":[{"given":"Sevil","family":"Kamali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuray Gurel","family":"Polat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esen","family":"Kasapoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Gul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lale","family":"Ocal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orhan","family":"Aral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meral","family":"Konice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selim","family":"Badur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"Inanc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,5,31]]},"reference":[{"key":"1104_CR1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/PL00011220","volume":"21","author":"K Aho","year":"2002","unstructured":"Aho K, Palosuo T (2002) Can outcome of early synovitis be predicted by serological tests? Clin Rheumatol 21:97\u2013102","journal-title":"Clin Rheumatol"},{"key":"1104_CR2","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/rheumatology\/35.7.620","volume":"35","author":"C Cordonnier","year":"1996","unstructured":"Cordonnier C, Meyer O, Palazzo E et al (1996) Diagnostic value of anti-RA33 antibody, antikeratin antibody, antiperinuclear factor and antinuclear antibody in early rheumatoid arthritis: comparison with rheumatoid factor. Br J Rheumatol 35:620\u2013624","journal-title":"Br J Rheumatol"},{"key":"1104_CR3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","volume":"43","author":"GA Schellekens","year":"2000","unstructured":"Schellekens GA, Visser H, de Jong BA et al (2000) The diagnostic properties of rheumatoid arthritis antibodies, recognizing a cyclic citrullinated peptide. Arthritis Rheum 43:155\u2013163","journal-title":"Arthritis Rheum"},{"key":"1104_CR4","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/ar93","volume":"2","author":"R Goldbach-Mansky","year":"2000","unstructured":"Goldbach-Mansky R, Lee J, Mc-Coy A et al (2000) Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res 2:236\u2013243","journal-title":"Arthritis Res"},{"key":"1104_CR5","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/clinchem\/47.6.1089","volume":"47","author":"N Bizzaro","year":"2001","unstructured":"Bizzaro N, Mazzanti G, Tonutti E, Villalta D, Tozzoli R (2001) Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis. Clin Chem 47:1089\u20131093","journal-title":"Clin Chem"},{"key":"1104_CR6","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1093\/rheumatology\/keg184","volume":"42","author":"S Bas","year":"2003","unstructured":"Bas S, Genevay S, Meyer O, Gabay C (2003) Anticyclic citrullinated peptide antibodies IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis. Rheumatology 42:677\u2013680","journal-title":"Rheumatology"},{"key":"1104_CR7","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1136\/ard.48.9.712","volume":"48","author":"C Vincent","year":"1989","unstructured":"Vincent C, Serre G, Lapeyre F et al (1989) High diagnostic value in rheumatoid arthritis of antibodies to the stratum corneum of rat oesophagus epithelium, so-called \u201cantikeratin antibodies\u201d. Ann Rheum Dis 48:712\u2013722","journal-title":"Ann Rheum Dis"},{"key":"1104_CR8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/art.10241","volume":"47","author":"A Saraux","year":"2002","unstructured":"Saraux A, Berthelot JM, Chales G et al (2002) Value of laboratory tests in early prediction of rheumatoid arthritis. Arthritis Rheum 47:155\u2013165","journal-title":"Arthritis Rheum"},{"key":"1104_CR9","first-page":"1451","volume":"30","author":"X Zeng","year":"2003","unstructured":"Zeng X, Ai M, Tian X et al (2003) Diagnostic value of anti-cyclic citrullinated peptide antibody in patients with rheumatoid arthritis. J Rheumatol 30:1451\u20131455","journal-title":"J Rheumatol"},{"key":"1104_CR10","first-page":"665","volume-title":"Oxford textbook of rheumatology, 2nd edn.","author":"PJ Maddison","year":"1998","unstructured":"Maddison PJ (1998) Autoantibody profile. In: Maddison PJ, Isenberg DA, Woo P, Glass DN (eds) Oxford textbook of rheumatology, 2nd edn. Oxford University Press, New York, pp 665\u2013676"},{"key":"1104_CR11","first-page":"2324","volume":"25","author":"BJ Harrison","year":"1998","unstructured":"Harrison BJ, Symmons DPM, Barrett EM, Silman AJ (1998) The performance of the 1987 ARA classification criteria for rheumatoid arthritis in a population-based cohort of patients with early inflammatory polyarthritis. J Rheumatol 25:2324\u20132330","journal-title":"J Rheumatol"},{"key":"1104_CR12","first-page":"485","volume":"10","author":"A Castro-Poltronieri","year":"1983","unstructured":"Castro-Poltronieri A, Alarcon-Segovia D (1983) Articular manifestations of primary Sjogren\u2019s syndrome. J Rheumatol 10:485","journal-title":"J Rheumatol"},{"key":"1104_CR13","first-page":"1301","volume-title":"Oxford textbook of rheumatology, vol II, 2nd edn.","author":"AG Tzioufas","year":"1998","unstructured":"Tzioufas AG, Youinou P, Moutsopoulos HM (1998) Sjogren\u2019s syndrome. In: Maddison PJ, Isenberg DA, Woo P, Glass DN (eds) Oxford textbook of rheumatology, vol II, 2nd edn. Oxford University Press, New York, pp 1301\u20131317"},{"key":"1104_CR14","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","volume":"116","author":"GS Hoffman","year":"1992","unstructured":"Hoffman GS, Kerr GS, Leavitt RY et al (1992) Wegener\u2019s granulomatosis: an analysis of 158 patients. Ann Intern Med 116:488\u2013498","journal-title":"Ann Intern Med"},{"key":"1104_CR15","first-page":"949","volume":"14","author":"DT Noritake","year":"1987","unstructured":"Noritake DT, Weiner SR, Bassett LW, Paulus HE, Weisbart R (1987) Rheumatic manifestations of Wegener\u2019s granulomatosis. J Rheumatol 14:949\u2013951","journal-title":"J Rheumatol"},{"key":"1104_CR16","first-page":"1635","volume-title":"Rheumatology, vol II, 3rd edn.","author":"JH Stone","year":"2003","unstructured":"Stone JH, Hoffman GS (2003) Wegener\u2019s granulomatosis and lymphomatoid granulomatosis. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH (eds) Rheumatology, vol II, 3rd edn. Elsevier Science, New York, pp 1635\u20131648"},{"key":"1104_CR17","first-page":"2064","volume":"30","author":"G Douglas","year":"2003","unstructured":"Douglas G, Bird K, Flume P, Silver R, Bolster M (2003) Wegener\u2019s granulomatosis in patients with rheumatoid arthritis. J Rheumatol 30:2064\u20132069","journal-title":"J Rheumatol"},{"key":"1104_CR18","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/ard.44.7.450","volume":"44","author":"P Youinou","year":"1985","unstructured":"Youinou P, Le Goff P, Colaco CB et al (1985) Antikeratin antibodies in serum and synovial fluid show specificity for rheumatoid arthritis in a study of connective tissue diseases. Ann Rheum Dis 44:450\u2013454","journal-title":"Ann Rheum Dis"},{"key":"1104_CR19","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/ard.2003.008623","volume":"63","author":"S Dubucquoi","year":"2004","unstructured":"Dubucquoi S, Solau-Gervais E, Lefranc D et al (2004) Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseases. Ann Rheum Dis 63:415\u2013419","journal-title":"Ann Rheum Dis"},{"key":"1104_CR20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1998","unstructured":"Arnett FC, Edworthy SM, Bloch DA et al (1998) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315\u2013324","journal-title":"Arthritis Rheum"},{"key":"1104_CR21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/bmj.2.6182.97","volume":"2","author":"BJJ Young","year":"1979","unstructured":"Young BJJ, Mallya RK, Leslie RDJ, Clark CJM, Hamblin TJ (1979) Anti-keratin antibodies in rheumatoid arthritis. BMJ 2:97\u201399","journal-title":"BMJ"},{"key":"1104_CR22","first-page":"173","volume":"135","author":"O Vittecoq","year":"2004","unstructured":"Vittecoq O, Incaurgarat B, Jouen-Beades F et al (2004) Autoantibodies recognizing citrullinated rat filaggrin in an ELISA using citrullinated and non-citrullinated recombinant proteins as antigens are highly diagnostic for rheumatoid arthritis. Clin Exp Rheumatol 135:173\u2013180","journal-title":"Clin Exp Rheumatol"},{"key":"1104_CR23","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/ard.60.1.67","volume":"60","author":"R Mediwake","year":"2001","unstructured":"Mediwake R, Isenberg DA, Schellekens GA, van Venrooij WJ (2001) Use of anti-citrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis 60:67\u201368","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-005-1104-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-005-1104-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-005-1104-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T14:18:42Z","timestamp":1586269122000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-005-1104-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,31]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["1104"],"URL":"https:\/\/doi.org\/10.1007\/s10067-005-1104-y","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5,31]]}}}